Patent · US Active

WT1 HLA class II-binding peptides and compositions and methods comprising same

US8765687B2 · kind B2 · utility

26Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2006
Grant dateJul 1, 2014
Priority date—
Expiry dateOct 26, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/57
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides WT1 peptides and methods of treating, reducing the incidence of, and inducing immune responses against a WT1-expressing cancer, comprising same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.